Skip to main content
Loading Nifty 50, Nifty Bank, and Sensex…

Wockhardt Limited

WOCKPHARMA · Corporate filings

Wockhardt Limited

WOCKPHARMA · NSE · Healthcare
₹2,054.00
0.95%
As of 12 Nov 2026

Wockhardt Limited (WOCKPHARMA) is listed on NSE in the Healthcare sector. It last traded at ₹2,054.00, up 0.95% on the session. Its 52-week range is ₹1,086.70 to ₹2,422.30.

Research output is rule-based and informational only. It is not investment advice.
Analytics for WOCKPHARMA are not available yet. Technicals, fundamentals, peer ranking and risk notes appear here once this listing's daily history and annual filings are synced.
Financial Charts & Report

Stock market charts for Wockhardt Limited quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.

Loading financial charts...

Results Change Summary quarter-on-quarter and year-on-year filing evidence

Generate an evidence-linked summary of revenue, margin, profit, debt, cash and operating cash flow changes.

Financial Results figures in ₹ crore, except EPS/%

Loading…

Relative Returns stock, sector, and exchange benchmarks

Loading…

CAN SLIM William O'Neil's growth-stock criteria

Loading…

Latest Shareholding Pattern promoter, FII, DII, public and institution trend

Loading shareholding pattern...

Corporate Governance SEBI integrated governance filing

Loading governance disclosure...

Announcements
Announcement
Credit rating
Announcement
Announcement
Announcement
Announcement
Market activity
Short selling - 10 shares
Announcement
Market activity
Short selling - 3 shares
Insider trading
Market activity
Short selling - 2 shares
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights Full history
Other Annual General Meeting Annual General Meeting Ex-date: 21 Jun 2024
Other Annual General Meeting Annual General Meeting Ex-date: 07 Aug 2023
Rights Rights 3:10@ Premium Rs 220 Per Share Rights 3:10@ Premium Rs 220 Per Share Ex-date: 08 Mar 2022
Other Annual General Meeting Annual General Meeting Ex-date: 23 Jul 2021
Other Annual General Meeting Annual General Meeting Ex-date: 24 Jul 2020
Other Annual General Meeting Annual General Meeting Ex-date: 02 Aug 2019
Other Annual General Meeting Annual General Meeting Ex-date: 25 Jul 2018
Other Annual General Meeting Annual General Meeting Ex-date: 24 Jul 2017
Dividend Interim Dividend Rs 10/- Per Share (Purose Revised) Interim Dividend Rs 10/- Per Share (Purose Revised) Ex-date: 17 Nov 2016
Other Annual General Meeting Annual General Meeting Ex-date: 04 Aug 2016
Other Annual General Meeting Annual General Meeting Ex-date: 03 Sep 2015
Dividend Interim Dividend - Rs 20/- Per Share Interim Dividend - Rs 20/- Per Share Ex-date: 13 Nov 2014
Other Annual General Meeting Annual General Meeting Ex-date: 04 Sep 2014
Dividend Interim Dividend - Rs 5/- Per Share Interim Dividend - Rs 5/- Per Share Ex-date: 17 Feb 2014
Dividend Interim Dividend Rs.5/- Per Share Interim Dividend Rs.5/- Per Share Ex-date: 07 Nov 2013
Dividend Annual General Meeting / Dividend Rs.5 Per Share Annual General Meeting / Dividend Rs.5 Per Share Ex-date: 22 Aug 2013
Other Annual General Meeting Annual General Meeting Ex-date: 03 Sep 2012
Other Annual General Meeting Annual General Meeting Ex-date: 30 Aug 2011
Other Annual General Meeting Annual General Meeting Ex-date: 08 Sep 2010
Other Annual General Meeting Annual General Meeting Ex-date: 19 Jun 2009
Board Meetings
02 Nov 2026
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations ); and in continuation to our letter bearing reference no: WOCK/SEC/SE/2026-27/042 dated 27th October, 2026, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 2nd November, 2026, inter-alia, has approved the Un-Audited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September, 2026;
10 Aug 2026
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations ); and in continuation to our letter bearing reference no: WOCK/SEC/SE/2026-27/027 dated 4th August, 2026, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 10th August, 2026, inter-alia, has approved the Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2026;
04 May 2026
Pursuant to Regulation 30 and 33 of Listing Regulations read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations ); and in continuation to our letter bearing reference no. Ref. No.: WOCK/SEC/SE/2026-27/006 dated 28th April, 2026, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 4th May, 2026, inter-alia, has approved:i. the Audited Financial Results and Financial Statements (Standalone & Consolidated) for the quarter and financial year ended 31st March, 2026. Kindly find enclosed herewith:a. Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended 31st March, 2026 along with Audit Report issued by M/s. M S K C & Associates LLP, Statutory Auditors of the Company on the same (enclosed as Annexure I); and b. Declaration on unmodified opinion on Audit Report (enclosed as Annexure II) ii Enabling proposal for raising of funds by issue of equity shares / securities convertible into equity shares/ non-convertible securities or any combination thereof in one or more tranches of public and/or private offerings, Qualified Institutions Placement and/or on preferential allotment basis or any combination thereof or any other method as may be permitted under applicable law, subject to consent of the shareholders at the ensuing Annual General Meeting and such approvals and compliances as may be required.
04 May 2026
Pursuant to Regulation 30 and 33 of Listing Regulations read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations ); and in continuation to our letter bearing reference no. Ref. No.: WOCK/SEC/SE/2026-27/006 dated 28th April, 2026, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 4th May, 2026, inter-alia, has approved:i. the Audited Financial Results and Financial Statements (Standalone & Consolidated) for the quarter and financial year ended 31st March, 2026. Kindly find enclosed herewith:a. Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended 31st March, 2026 along with Audit Report issued by M/s. M S K C & Associates LLP, Statutory Auditors of the Company on the same (enclosed as Annexure I); and b. Declaration on unmodified opinion on Audit Report (enclosed as Annexure II) ii Enabling proposal for raising of funds by issue of equity shares / securities convertible into equity shares/ non-convertible securities or any combination thereof in one or more tranches of public and/or private offerings, Qualified Institutions Placement and/or on preferential allotment basis or any combination thereof or any other method as may be permitted under applicable law, subject to consent of the shareholders at the ensuing Annual General Meeting and such approvals and compliances as may be required.
10 Feb 2026
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations ); and in continuation to our letter bearing reference no: WOCK/SEC/SE/2025-26/065 dated 4th February, 2026, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e.10th February, 2026, inter-alia, has approved the Un-Audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2025.